Cambridge Investment Research Advisors, Inc. Innovator Etfs Tr Ibd Breakout Transaction History

Cambridge Investment Research Advisors, Inc.

$26 Billion
Q1 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	N/A	-5,296 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	N/A	-3,150 Reduced 37.3%	5,296 $0
Q3 2021 Nov 02, 2021	BUY	N/A	250 Added 3.05%	8,446 $0
Q2 2021 Aug 10, 2021	SELL	N/A	-200 Reduced 2.38%	8,196 $0
Q1 2021 May 07, 2021	BUY	N/A	8,396 New	8,396 $0

Others Institutions Holding BOUT

# of Institutions

Shares Held

46.4K

Call Options Held

Put Options Held

Ken Griffin Citadel Advisors LLC | Chicago, Il

30.3K
Shares

$1.07 Million
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

7.69K
Shares

$271,930
0.0% of portfolio
Advisor Group Holdings, Inc. Phoenix, AZ

5.37K
Shares

$189,849
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

1.33K
Shares

$46,878
0.0% of portfolio
Asset Dedication, LLC

577
Shares

$20,414
0.0% of portfolio

View Full List

About INNOVATOR ETFS TR IBD BREAKOUT

Ticker BOUT
Sector ETFs
Industry ETFs

More about BOUT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account